Brief: Sakar Healthcare Enters Into Agreement With Zydus Life Sciences To Manufacture Anti-Cancer Products
06/10/2022 11:44
Oct 6 (Reuters) - Sakar Healthcare Ltd SAKA.NS :
* ENTERS INTO AGREEMENT WITH ZYDUS LIFE SCIENCES (CADILA
HEALTHCARE) TO MANUFACTURE ANTI-CANCER PRODUCTS
Source text for Eikon: ID:nNSE8Z6w8d
Further company coverage: SAKA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar